Dna Link, Inc. (South Korea)

DNA-Link, Inc. is a genome-based biotechnology company located in Seoul, South Korea. It was established on March 3, 2000. The company has focused on research and development in the bio industry and genome analysis industry for over 20 years, resulting in a wealth of research results and technology. DNA-Link aims to be a Frontier Company in Personalized Medicine. They utilize the latest genome mass analysis technology to analyze and research various genome information, including DNA and RNA of humans and all living things. The company specializes in generating high-quality genomic data and has expertise in analyzing and interpreting results. DNA-Link's main focus is on applying bioinformatics analysis technology to establish a genome information database, identify genetic characteristics of populations, discover genomic biomarkers, and perform convergence analysis between genomic information and clinical information. They have pioneered a new analysis trend that combines bio technology and information technology. The company operates not only in Korea but also in Asia and globally. They are leading personalized medical businesses, including medical technology and new drug development, through genome analysis. Their ultimate goal is to contribute to improving the health and quality of life of people by improving the cure rate of diseases and extending human life expectancy. DNA-Link plans to achieve this by continuously engaging in research and development, taking on new challenges, and providing a foundation for customized treatment. They aim to enable the prevention and early diagnosis of diseases and apply prevention and treatment management methods suitable for individuals based on their genetic differences.